Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Viana (Leiria, Portugal), J. Cordeiro Da Costa (Leiria, Portugal), E. Gomes (Leiria, Portugal), S. Feijó (Leiria, Portugal). Eosinophils: a biological marker for bronchiectasis exacerbations?. 2873

Member's Comments

No comment yet.

Related content which might interest you: COPD exacerbations: is eosinophilia a protective factor? Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Cells biomarkers of bronchial brush-biopsies at COPD exacerbation Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Inflammatory markers during bronchiolitis, relation to persistent asthma? Source: Annual Congress 2010 - Risk factors for allergic diseases in children Year: 2010 Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 The biology of pulmonary exacerbations in bronchiectasis Source: Eur Respir Rev, 28 (154) 190055; 10.1183/16000617.0055-2019 Year: 2019 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD? Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Can red blood cell morphology be an indicator for COPD exacerbations? Source: International Congress 2014 – Markers Year: 2014 Infectious exacerbations of COPD: IL-18 and its relation to markers of inflammation Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020 Bronchial asthma: what is different in patients with and without chronic cough? Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 Proteinase-3 as a biomarker of exacerbations in bronchiectasis. Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Pulmonary and systemic inflammation in patients with AECOPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Acute exacerbations of IPF: A neglected threat in IPF ? Source: ERS webinars 2019 - Acute exacerbations of IPF Year: 2019 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016